Full text is available at the source.
Abstract
Psilocybin shows potential as a treatment for various psychiatric conditions, including treatment-resistant depression and post-traumatic stress disorder.
- A growing body of evidence suggests effectiveness in treating psychiatric conditions such as generalized anxiety disorder and substance use disorders.
- Psilocybin acts as a serotonin 2A receptor agonist, influencing brain networks related to emotional regulation and cognitive flexibility.
- Controlled trials indicate that psilocybin, used alongside structured psychotherapy, can lead to lasting improvements in mood and emotional well-being.
- Mild and self-limiting side effects, such as nausea and headaches, suggest a favorable safety profile.
- Further research is needed to optimize dosing and assess long-term safety and effectiveness.
Simplified